Amanote Research
Register
Sign In
Epiretinal Membranes in a Db/Db Model of Diabetic Retinopathy
Acta Ophthalmologica
- United States
doi 10.1111/aos.13972_47
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Ophthalmology
Date
December 1, 2018
Authors
Unknown
Publisher
Wiley
Related search
Supplemental Information 1: Establishment of Db/Db Diabetic Mice Model
MicroRNA-29b Inhibits Diabetic Nephropathy in Db/Db Mice
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Figure 1: Illustration of Experimental Schedule and Establishment of Db/Db Diabetic Mice Model.
Differential Effect of Statins on Diabetic Nephropathy in Db/Db Mice
International Journal of Molecular Medicine
Medicine
Genetics
Segmentation of the Pathophysiological Stages of Diabetic Changes in the Db/Db Mouse
Journal of Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Figure 3: Rosiglitazone Administration Increased Wound Angiogenesis in Db/Db Diabetic Mice.
Figure 2: Rosiglitazone Administration Accelerated Wound Closure in Db/Db Diabetic Mice.
Activator Protein-1 in Epiretinal Membranes of Patients With Proliferative Diabetic Retinopathy
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
The LXR Ligand T0901317 Induces Severe Lipogenesis in the Db/Db Diabetic Mouse
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
